Article info

Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment

Authors

  1. Correspondence to Linn Persson Berg; linn.persson.berg{at}gu.se
View Full Text

Citation

Persson Berg L, Eriksson M, Longhi S, et al
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment

Publication history

  • Received January 17, 2022
  • Accepted July 13, 2022
  • First published July 27, 2022.
Online issue publication 
July 27, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.